Cargando…

A Single Administration of OC-01 (Varenicline Solution) Nasal Spray Induces Short-Term Alterations in Conjunctival Goblet Cells in Patients with Dry Eye Disease

INTRODUCTION: Dry eye disease is characterized by a persistently unstable or deficient tear film causing discomfort or visual impairment. Varenicline is a small-molecule nicotinic acetylcholine receptor agonist recently approved for use as a preservative-free nasal spray (OC-01 [varenicline solution...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dieckmann, Gabriela M., Cox, Stephanie M., Lopez, Maria J., Ozmen, M. Cuneyt, Yavuz Saricay, Leyla, Bayrakutar, Betul N., Binotti, William W., Henry, Eugenia, Nau, Jeffrey, Hamrah, Pedram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253229/ https://www.ncbi.nlm.nih.gov/pubmed/35653029 http://dx.doi.org/10.1007/s40123-022-00530-x

Ejemplares similares

Semi-PBPK Modeling and Simulation to Evaluate the Local and Systemic Pharmacokinetics of OC-01(Varenicline) Nasal Spray
por: Wu, Xiaofei, et al.
Publicado: (2022)

OC-01 (Varenicline Solution) Nasal Spray Demonstrates Consistency of Effect Regardless of Age, Race, Ethnicity, and Artificial Tear Use
por: Epitropoulos, Alice T, et al.
Publicado: (2022)

ONSET-1 Phase 2b Randomized Trial to Evaluate the Safety and Efficacy of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease
por: Wirta, David, et al.
Publicado: (2022)

OC-01 (Varenicline Solution) Nasal Spray for the Treatment of Dry Eye Disease Signs and Symptoms in Subjects with Autoimmune Disease: Integrated Data from ONSET-1 and ONSET-2
por: Schallhorn, Julie M, et al.
Publicado: (2023)

Automated Image Threshold Method Comparison for Conjunctival Vessel Quantification on Optical Coherence Tomography Angiography
por: Binotti, William W., et al.
Publicado: (2022)

Matching-adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry eye disease
por: White, Darrell E, et al.
Publicado: (2023)

Comparison of clinical characteristics of post-refractive surgery-related and post-herpetic neuropathic corneal pain
por: Bayraktutar, Betul N., et al.
Publicado: (2020)

Does Menopausal Status Affect Dry Eye Disease Treatment Outcomes with OC-01 (Varenicline Solution) Nasal Spray? A Post Hoc Analysis of ONSET-1 and ONSET-2 Clinical Trials
por: Nijm, Lisa M., et al.
Publicado: (2022)

In vivo fluorescence imaging of conjunctival goblet cells
por: Kim, Seonghan, et al.
Publicado: (2019)

Modulation of Conjunctival Goblet Cell Function by Inflammatory Cytokines
por: Contreras-Ruiz, L., et al.
Publicado: (2013)

The protective role of conjunctival goblet cell mucin sialylation
por: Matsuzawa, Moe, et al.
Publicado: (2023)

Effect of topical rebamipide on conjunctival goblet cell recovery after vitrectomy
por: Kato, Kumiko, et al.
Publicado: (2016)

Immunomodulatory Cross-Talk between Conjunctival Goblet Cells and Dendritic Cells
por: Contreras-Ruiz, Laura, et al.
Publicado: (2015)

Context-Dependent Regulation of Conjunctival Goblet Cell Function by Allergic Mediators
por: García-Posadas, Laura, et al.
Publicado: (2018)

Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
por: Bakker, D.S., et al.
Publicado: (2019)

Varenicline Solution Nasal Spray: A Review in Dry Eye Disease
por: Frampton, James E.
Publicado: (2022)

Artificial Polymeric Scaffolds as Extracellular Matrix Substitutes for Autologous Conjunctival Goblet Cell Expansion
por: He, Min, et al.
Publicado: (2016)

IL‐4 and IL‐13 both contribute to the homeostasis of human conjunctival goblet cells in vitro
por: Hansen, Pernille M., et al.
Publicado: (2022)

Ambient Levels of Air Pollution Induce Goblet-Cell Hyperplasia in Human Conjunctival Epithelium
por: Novaes, Priscila, et al.
Publicado: (2007)

Staphylococcus aureus Activates the NLRP3 Inflammasome in Human and Rat Conjunctival Goblet Cells
por: McGilligan, Victoria E., et al.
Publicado: (2013)

Inhibition of microRNA-328 Increases Ocular Mucin Expression and Conjunctival Goblet Cells
por: Choo, Jackson, et al.
Publicado: (2023)

Lipoxin A(4) Counter-regulates Histamine-stimulated Glycoconjugate Secretion in Conjunctival Goblet Cells
por: Hodges, Robin R., et al.
Publicado: (2016)

Activation of the EGF Receptor by Histamine Receptor Subtypes Stimulates Mucin Secretion in Conjunctival Goblet Cells
por: He, Min, et al.
Publicado: (2018)

High expression of SARS-CoV-2 entry factors in human conjunctival goblet cells
por: Ma, Ruiqi, et al.
Publicado: (2021)

Sex-based differences in conjunctival goblet cell responses to pro-inflammatory and pro-resolving mediators
por: Yang, Menglu, et al.
Publicado: (2022)

Investigation of Conjunctival Goblet Cell and Tear MUC5AC Protein in Patients With Graves’ Ophthalmopathy
por: You, Yayan, et al.
Publicado: (2023)

Safety, adherence and discontinuation in varenicline solution nasal spray clinical trials for dry eye disease
por: Hauswirth, Scott G, et al.
Publicado: (2023)

Effects of mycophenolate mofetil on proliferation and mucin-5AC expression in human conjunctival goblet cells in vitro
por: He, Hong, et al.
Publicado: (2010)

The effect of nerve growth factor on differentiation of corneal limbal epithelial cells to conjunctival goblet cells in vitro
por: Li, Weiwei, et al.
Publicado: (2010)

Lipoxin A(4) activates ALX/FPR2 Receptor to Regulate Conjunctival Goblet Cell Secretion
por: Hodges, Robin R., et al.
Publicado: (2016)

The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease
por: Simsek, Cem, et al.
Publicado: (2019)

Bioelectric Responses of Conjunctival Goblet Cells to Dry Eye: Impact of Ion Channels on Exocytotic Function and Viability
por: Puro, Donald G.
Publicado: (2020)

Conjunctival Goblet Cell Responses to TLR5 Engagement Promote Activation of Local Antigen-Presenting Cells
por: Logeswaran, Abiramy, et al.
Publicado: (2021)

Could APO-varenicline and cytisine be solutions for the shortage of varenicline in Brazil?
por: Corrêa, Paulo César Rodrigues Pinto, et al.
Publicado: (2023)

Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker
por: Usuba, Fany Solange, et al.
Publicado: (2020)

Bilateral Nerve Alterations in a Unilateral Experimental Neurotrophic Keratopathy Model: A Lateral Conjunctival Approach for Trigeminal Axotomy
por: Yamaguchi, Takefumi, et al.
Publicado: (2013)

Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008)

Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?
por: Sheppard, John D., et al.
Publicado: (2023)

Resolvin D1 and Aspirin-Triggered Resolvin D1 Regulate Histamine-stimulated Conjunctival Goblet Cell Secretion
por: Li, Dayu, et al.
Publicado: (2013)

Resolvin D1 Increases Mucin Secretion in Cultured Rat Conjunctival Goblet Cells via Multiple Signaling Pathways
por: Lippestad, Marit, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6n8bvldosfqjgk22s4pclbpkr6